BioNexus Gene Lab Corp. (BGLC)
4.15
+0.01
(+0.24%)
USD |
NASDAQ |
Dec 16, 16:00
4.15
0.00 (0.00%)
After-Hours: 16:32
BioNexus Gene Lab Profit Margin (Quarterly): -27.87% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Balchem Corp. | 15.06% |
| Innospec, Inc. | 2.92% |
| Alto Ingredients, Inc. | 5.90% |
| WD-40 Co. | 12.96% |
| General Enterprise Ventures, Inc. | -2.75K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -28.84% |
| Return on Assets | -23.95% |
| Return on Invested Capital | -28.12% |
| Gross Profit Margin (Quarterly) | 14.85% |
| Operating Margin (Quarterly) | -31.85% |
| Return on Net Operating Assets | -44.92% |